{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T05:07:10Z","timestamp":1779944830232,"version":"3.53.1"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To systematically quantify the graded relationship between serum resistin levels and the severity of coronary heart disease (CHD) using a network meta-analysis, thereby evaluating its potential as a biological marker of disease progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a comprehensive search of major international and Chinese databases up to December 2025. A random-effects network meta-analysis was performed to calculate standardized mean differences (SMD) and Surface Under the Cumulative Ranking (SUCRA) values. Subgroup, sensitivity, and Trim-and-Fill analyses were conducted to investigate heterogeneity and publication bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 26 studies (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20099,169 subjects) were included. The network meta-analysis (5,450 individuals) demonstrated a progressive, stepwise increase in serum resistin levels across the disease spectrum: from healthy controls (CHD-), to stable CHD (SMD\u2009=\u20090.77, 95% CI: 0.38\u20131.15), to acute coronary syndrome (ACS; SMD\u2009=\u20091.88, 95% CI: 1.22\u20132.54), and culminating in acute myocardial infarction (AMI; SMD\u2009=\u20094.68, 95% CI: 3.92\u20135.43), all compared to controls. SUCRA rankings confirmed this clear hierarchy (AMI\u2009&amp;gt;\u2009ACS\u2009&amp;gt;\u2009stable CHD\u2009&amp;gt;\u2009CHD-). However, substantial heterogeneity (I\u00b2=95.8%) and evidence of publication bias were detected.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Serum resistin levels show a clear, graded association with CHD severity, positioning resistin as a potent biological correlate of the underlying inflammatory burden. However, due to significant heterogeneity and publication bias that likely inflate the observed effect sizes, resistin is not suitable as a standalone diagnostic tool. Its potential clinical utility may lie as an adjunctive marker in multi-biomarker models for risk stratification, a role that requires validation in large-scale prospective studies using standardized assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:ext-link>\n                      , PROSPERO CRD420261397089.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1774421","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:51:42Z","timestamp":1779943902000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum resistin as a potential biomarker for stratifying the severity of coronary heart disease: a network meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Yicheng","family":"Ling","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of China Medical University","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Wei","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of China Medical University","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiapeng","family":"Luo","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of China Medical University","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiang","family":"Gu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of China Medical University","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Jiang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of China Medical University","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1161\/CIRCRESAHA.117.311849","article-title":"Reducing the global burden of cardiovascular disease, part 2: prevention and treatment of cardiovascular disease","volume":"121","author":"Leong","year":"2017","journal-title":"Circ Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1093\/eurheartj\/ehz372","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the academic research consortium for high bleeding risk","volume":"40","author":"Urban","year":"2019","journal-title":"Eur Heart J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00246-024-03512-x","article-title":"Machine learning to predict outcomes of fetal cardiac disease: a pilot study","volume":"46","author":"Nield","year":"2025","journal-title":"Pediatr Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and inflammation in atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12964-022-01032-w","article-title":"Resistin-like molecules: a marker, mediator and therapeutic target for multiple diseases","volume":"21","author":"Shi","year":"2023","journal-title":"Cell Commun Signal"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1038\/oby.2005.215","article-title":"Association of plasma resistin levels with coronary heart disease in women","volume":"13","author":"Pischon","year":"2005","journal-title":"Obes Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.cyto.2006.05.005","article-title":"Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes","volume":"34","author":"Yaturu","year":"2006","journal-title":"Cytokine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1631\/jzus.2007.B0875","article-title":"Relationship between resistin level in serum and acute coronary syndrome or stable angina pectoris","volume":"8","author":"Qiao","year":"2007","journal-title":"J Zhejiang Univ Sci B"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2007.07.001","article-title":"Relationship between the adipose-tissue hormone resistin and coronary artery disease","volume":"386","author":"Hoefle","year":"2007","journal-title":"Clin Chim Acta"},{"key":"B10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.atherosclerosis.2006.05.039","article-title":"Resistin, acute coronary syndrome and prognosis results from the AtheroGene study","volume":"193","author":"Lubos","year":"2007","journal-title":"Atherosclerosis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1097\/00029330-200705020-00004","article-title":"Plasma resistin is increased in patients with unstable angina","volume":"120","author":"Hu","year":"2007","journal-title":"Chin Med J (Engl)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1001-9294(09)60082-1","article-title":"High serum resistin level may be an indicator of the severity of coronary disease in acute coronary syndrome","volume":"24","author":"Wang","year":"2009","journal-title":"Chin Med Sci J"},{"key":"B13","first-page":"599","article-title":"Relationship of serum angiogenin, adiponectin and resistin levels with biochemical risk factors and the angiographic severity of three-vessel coronary disease","volume":"17","author":"Kr\u0119cki","year":"2010","journal-title":"Cardiol J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/ijo.2009.204","article-title":"Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME","volume":"34","author":"Luc","year":"2010","journal-title":"Int J Obes"},{"key":"B15","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.clinbiochem.2011.02.013","article-title":"Heritability of genetic variants of resistin gene in patients with coronary artery disease: a family-based study","volume":"44","author":"Hussain","year":"2011","journal-title":"Clin Biochem"},{"key":"B16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/pgmj.2010.113571","article-title":"Serum resistin in acute myocardial infarction patients with and without diabetes mellitus","volume":"87","author":"Korah","year":"2011","journal-title":"Postgrad Med J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2217\/bmm.11.104","article-title":"Circulating levels of resistin, IL-6 and lipid profile in elderly patients with ischemic heart disease with and without diabetes","volume":"6","author":"Yaseen","year":"2012","journal-title":"Biomark Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.5603\/KP.a2013.0086","article-title":"Prognostic value of serum resistin levels in patients with acute myocardial infarction","volume":"72","author":"Erer","year":"2014","journal-title":"Kardiol Pol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e64729","DOI":"10.1371\/journal.pone.0064729","article-title":"Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes","volume":"8","author":"Menzaghi","year":"2013","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00011-014-0771-z","article-title":"Adiponectin-resistin index and its strong association with acute coronary syndrome in South Indian men","volume":"63","author":"Singh","year":"2014","journal-title":"Inflamm Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1177\/0003319713502718","article-title":"Relationship between increased serum resistin level and severity of coronary artery disease","volume":"65","author":"Sinan","year":"2014","journal-title":"Angiology"},{"key":"B22","first-page":"37","article-title":"Adipokines and endothelial dysfunction in acute myocardial infarction and the risk of recurrent cardiovascular events","volume":"16","author":"Grzywocz","year":"2015","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"B23","doi-asserted-by":"crossref","first-page":"e0151916","DOI":"10.1371\/journal.pone.0151916","article-title":"Inflammation activation contributes to adipokine imbalance in patients with acute coronary syndrome","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"B24","first-page":"445","article-title":"Serum resistin levels in patients of hypertension and coronary artery disease","volume":"10","author":"Niaz","year":"2016","journal-title":"Pak J Med Health Sci"},{"key":"B25","first-page":"7","article-title":"The association between serum resistin level and presence or severity of coronary heart disease","volume":"11","author":"Mortazavi","year":"2017","journal-title":"Int Cardiovasc Res J"},{"key":"B26","first-page":"267","article-title":"Is there a relationship between resistin levels and left ventricular end-diastolic pressure?","volume":"19","author":"Yildirim","year":"2018","journal-title":". Anatol J Cardiol"},{"key":"B27","first-page":"46","article-title":"Resistin and prooxidant-antioxidant balance: markers to discriminate acute coronary syndrome from stable angina","volume":"16","author":"Pourmoghaddas","year":"2020","journal-title":"ARYA Atheroscler"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e18450","DOI":"10.7759\/cureus.18450","article-title":"Study of some inflammatory mediators in the serum of patients with atherosclerosis and acute myocardial infarction","volume":"13","author":"Metwalli","year":"2021","journal-title":"Cureus"},{"key":"B29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.atherosclerosis.2022.06.610","article-title":"Assessment of adipokines levels and lipid profile in overweight and obese patients depending on the presence of coronary heart disease","volume":"355","author":"Prus","year":"2022","journal-title":"Atherosclerosis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.atherosclerosis.2022.06.611","article-title":"Lipid profile and adipokines levels in overweight and obese patients","volume":"355","author":"Prus","year":"2022","journal-title":"Atherosclerosis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3000605251325162","DOI":"10.1177\/03000605251325162","article-title":"Circulating leptin and resistin levels in myocardial infarction patients with insulin resistance","volume":"53","author":"Dera","year":"2025","journal-title":"J Int Med Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.3390\/molecules25215218","article-title":"An overview of the role of adipokines in cardiometabolic diseases","volume":"25","author":"Farkhondeh","year":"2020","journal-title":"Molecules"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e290721195114","DOI":"10.2174\/1573403X17666210729101120","article-title":"Resistin and cardiovascular disease: a review of the current literature regarding clinical and pathological relationships","volume":"18","author":"Askin","year":"2022","journal-title":"Curr Cardiol Rev"},{"key":"B34","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1476-5381.2011.01369.x","article-title":"Resistin: functional roles and therapeutic considerations for cardiovascular disease","volume":"165","author":"Jamaluddin","year":"2012","journal-title":"Br J Pharmacol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1681\/ASN.2010050524","article-title":"Hypertension: shall we focus on adipose tissue?","volume":"21","author":"Bo","year":"2010","journal-title":". J Am Soc Nephrol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1161\/STROKEAHA.120.030228","article-title":"Expression of resistin, chemerin, and chemerin\u2019s receptor in the unstable carotid atherosclerotic plaque","volume":"52","author":"Yanofsky","year":"2021","journal-title":"Stroke"},{"key":"B37","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4093\/dmj.2013.37.6.404","article-title":"Resistin in rodents and humans","volume":"37","author":"Park","year":"2013","journal-title":"Diabetes Metab J"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.3390\/diagnostics14232677","article-title":"Adipokines and cardiometabolic heart failure with preserved ejection fraction: a state-of-the-art review","volume":"14","author":"Theodorakis","year":"2024","journal-title":"Diagnostics"},{"key":"B39","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1536\/ihj.20-221","article-title":"Human resistin and cardiovascular disease","volume":"61","author":"Yuxiang","year":"2020","journal-title":"Int Heart J"},{"key":"B40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cca.2020.11.010","article-title":"Resistin: potential biomarker and therapeutic target in atherosclerosis","volume":"512","author":"Zhou","year":"2021","journal-title":"Clin Chim Acta"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1774421\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:51:52Z","timestamp":1779943912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1774421\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":40,"alternative-id":["10.3389\/fcvm.2026.1774421"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1774421","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"article-number":"1774421"}}